Vir Biotechnology (VIR) Depreciation and Depletion (2023 - 2026)

Vir Biotechnology's Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Depreciation and Depletion fell 3.57% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $11.3 million (down 10.32% YoY), while the FY2025 annual figure was $11.4 million, down 19.72% from the prior year.
• Depreciation and Depletion came in at $2.7 million for Q1 2026 at Vir Biotechnology, down from $2.8 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $5.5 million in Q1 2023 to a low of $2.7 million in Q4 2024.
• A 4-year average of $3.6 million and a median of $2.9 million in 2024 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion sank 37.21% in 2024 and climbed 3.7% in 2025, its largest moves.
• Vir Biotechnology's Depreciation and Depletion stood at $4.3 million in 2023, then tumbled by 37.21% to $2.7 million in 2024, then gained by 3.7% to $2.8 million in 2025, then slipped by 3.57% to $2.7 million in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $2.7 million, $2.8 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison